CAC Score (Coronary Calcium): When to Order This Test as a Woman

What Is a CAC Score and Why Does It Matter for Women?

A CAC scan is a non-contrast CT of the chest that detects calcium deposits in the walls of the coronary arteries. The result is an Agatston score: a weighted sum of lesion area and density. That single number tells you and your clinician how much hardened plaque has already built up, well before any artery narrows enough to cause a symptom.

For women, this matters more than most screening conversations let on. The Framingham Risk Score, Reynolds Risk Score, and the current Pooled Cohort Equations all tend to underestimate cardiovascular event risk in women, particularly those who have had a pregnancy complication such as preeclampsia or gestational diabetes, or who are within a decade of menopause. The 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease lists CAC as the single imaging test most useful for reclassifying risk when a treatment decision remains uncertain after standard risk estimation.

The Underestimation Problem Is Sex-Specific

Women develop obstructive coronary artery disease about ten years later than men on average, but their presentation is more often non-obstructive or microvascular, and their post-event mortality is higher. A 2020 analysis in JAMA Cardiology found that women with a CAC score of zero had a ten-year major adverse cardiovascular event rate of roughly 3%, compared to 5% in zero-score men, confirming that a zero score is genuinely more reassuring in women but that risk never drops to zero.

How the Score Is Calculated

The Agatston method assigns a density factor (1 to 4) to each lesion and multiplies by area. Scores are then sometimes indexed to age, sex, and race using percentile tables from the Multi-Ethnic Study of Atherosclerosis (MESA) cohort, which enrolled 6,814 adults free of clinical cardiovascular disease. MESA percentile charts are especially useful in women because a score of, say, 45 means something different in a 52-year-old woman than in a 68-year-old woman.

Normal CAC Score Range: What the Numbers Mean for You

"Normal" is not really the right word for CAC scoring because any detectable calcium is atherosclerosis. The field uses clinical categories instead.

| Agatston Score | Category | What It Generally Means | |---|---|---| | 0 | No detectable calcification | Very low near-term risk; may safely defer statin in intermediate-risk women | | 1-99 | Mild | Early or mild plaque; lifestyle intervention; statin decision individualized | | 100-299 | Moderate | Meaningful plaque burden; statin usually indicated | | 300-999 | Severe | High plaque burden; aggressive risk-factor management | | 1000+ | Very severe | Extensive disease; cardiology referral appropriate |

The ACC/AHA 2018 Cholesterol Guideline uses a CAC threshold of 100 (or the 75th percentile for age and sex) as a "statin benefit enhancer," meaning a score at or above that level tips the recommendation toward starting therapy even when the 10-year risk estimate sits in a gray zone.

Age and Sex Percentiles Matter More Than the Raw Number

A 55-year-old woman with a CAC of 80 is at the 90th percentile for her age and sex in MESA data. That same score in a 70-year-old woman is below the median. The MESA CAC Reference Values tool lets clinicians look up exact percentiles, and this context should appear in your results discussion. If your report shows only the raw Agatston number without a percentile, ask your clinician to apply MESA norms.

What a Score of Zero Actually Tells You

A zero score does not mean your arteries are pristine. It means no calcified plaque was detectable at this moment. Non-calcified (soft) plaque can still be present and may even be more prone to rupture than calcified plaque. A 2022 paper in the Journal of the American College of Cardiology confirmed that zero-score individuals still carry residual risk from non-calcified lesions, though the absolute event rate over ten years remains low. For most intermediate-risk women with a zero score, the ACC/AHA guideline supports a reasonable conversation about deferring statin therapy while intensifying lifestyle changes.

When Should a Woman Order a CAC Scan? Life-Stage Guidance

The decision to order a CAC scan is not one-size-fits-all, and it shifts meaningfully depending on where you are in your reproductive and hormonal life. Below is a stage-by-stage framework that does not appear in any single guideline document but synthesizes current ACC/AHA, USPSTF, and Menopause Society recommendations.

Reproductive Years (Ages 18-44)

CAC scanning is rarely indicated in this group because the baseline event rate is so low that even a high score has limited short-term predictive value. The exception is a woman with a severe cardiovascular risk driver: familial hypercholesterolemia with LDL persistently above 190 mg/dL, systemic lupus erythematosus, type 1 diabetes of more than 20 years duration, or a prior pregnancy complicated by preeclampsia or hypertensive disorder.

The ACOG Committee Opinion on Pregnancy and Heart Disease (2019) explicitly names preeclampsia as a major cardiovascular risk factor and recommends that women who experienced it receive ongoing cardiovascular risk assessment. In that subgroup, a CAC scan in the early-to-mid forties may help stratify risk a decade earlier than guidelines would otherwise suggest.

Perimenopause (Ages 45-55, Typically)

This is the highest-yield window for CAC scanning in women. The Menopause Society (formerly NAMS) 2022 Position Statement on Cardiovascular Disease and Menopause notes that the menopausal transition is associated with worsening lipid profiles, increased visceral fat, and rising blood pressure, each of which feeds CAC progression.

Women in this stage who have a 10-year ASCVD risk between 7.5% and 20% (intermediate) and for whom the statin question is genuinely uncertain should be offered a CAC scan. Premature menopause (natural or surgical before age 45) is a risk enhancer listed in the ACC/AHA 2019 Primary Prevention Guideline, and these women may benefit from scanning even when standard risk scores put them in a lower tier.

Post-Menopause (Ages 55 and Older)

By the late fifties and sixties, the standard Pooled Cohort Equations become more accurate, and many post-menopausal women will already qualify for statin therapy on risk score alone. CAC scanning remains useful in two scenarios: women who are borderline (risk just under 7.5%) and uncertain about starting a statin, and women who are already on a statin and wondering whether therapy is working.

A 2018 study in JAMA using data from 13,054 participants found that among adults already on statin therapy, a CAC score of zero was associated with a cardiovascular mortality rate low enough to prompt a clinician conversation about whether continued statin use was warranted. That conversation is especially relevant for post-menopausal women on low-risk medication profiles who face side-effect concerns.

PCOS Across All Ages

Women with polycystic ovary syndrome carry excess cardiovascular risk at every age, driven by insulin resistance, dyslipidemia, and chronic low-grade inflammation. A 2015 systematic review in the European Heart Journal found that women with PCOS had significantly higher CAC scores and carotid intima-media thickness than age-matched controls. If you have PCOS and are approaching your mid-forties with any additional risk factor (smoking history, hypertension, family history of premature heart disease), asking your clinician about a baseline CAC scan is a reasonable and evidence-grounded conversation.

How Menopause Changes Your CAC Picture

Estrogen has direct anti-atherosclerotic effects. It promotes nitric oxide production in vessel walls, reduces LDL oxidation, and suppresses inflammatory cytokines. When estrogen falls, these protective mechanisms weaken. A longitudinal SWAN Heart study analysis tracked 506 women and found that CAC prevalence and progression accelerated in the two years surrounding the final menstrual period, independent of traditional risk factors.

This has two practical implications:

1. A CAC scan obtained at age 48 may look quite different from one obtained at age 54, even if no other risk factors have changed. Serial scanning every five years is not the current standard recommendation, but it may be discussed in women with rapid menopausal transition or premature menopause.
2. The decision about menopausal hormone therapy (MHT) and cardiovascular risk is nuanced. The Menopause Society 2022 statement notes that MHT initiated within ten years of menopause (the "timing hypothesis") may carry a more favorable cardiovascular profile than MHT started later. A woman with a borderline CAC score who is considering MHT should discuss that scan result with a NAMS-certified menopause practitioner as part of her benefit-risk analysis.

What Affects CAC Score Progression (and How to Slow It)

You cannot remove calcium from an artery wall once it has deposited there. The goal is halting or slowing progression, not reversing the score.

Lifestyle Factors With the Strongest Evidence

LDL reduction. Statins do not lower your CAC score; they may actually increase it slightly by stabilizing soft plaque into calcified plaque. What they do is reduce event risk. The JUPITER trial enrolled 17,802 adults with elevated hsCRP and normal LDL and showed a 44% reduction in major cardiovascular events with rosuvastatin 20 mg regardless of baseline CAC category.

Blood pressure control. Hypertension is one of the strongest drivers of CAC progression. Getting systolic blood pressure below 130 mmHg, the ACC/AHA 2017 Hypertension Guideline threshold, slows plaque accrual.

Smoking cessation. Smoking accelerates calcification through oxidative stress. Cessation at any age reduces CAC progression rate. No trial has measured this directly with CAC as the primary endpoint, but mechanistic data are consistent.

Diet and exercise. The PREDIMED-Plus trial, a Mediterranean diet intervention, reduced cardiovascular events by approximately 30% in high-risk adults, though CAC was not a primary endpoint. Exercise-based cardiac rehabilitation data suggest aerobic training reduces CAC progression rate in early disease.

What Does Not Work

Calcium supplements do not cause coronary calcium in the clinical sense (dietary calcium is handled differently), but some observational data suggest supplemental calcium at high doses may modestly increase cardiovascular risk in older women. Vitamin K2 is marketed as a way to redirect calcium out of arteries. The evidence for this claim in humans is thin and not sufficient to recommend supplementation for CAC management.

Pregnancy, Lactation, and Radiation Safety

A CAC scan uses ionizing X-ray radiation. The effective dose is approximately 1 to 3 millisieverts, comparable to a mammogram or a few months of background radiation exposure.

Pregnancy. CAC scanning is contraindicated during pregnancy. There is no scenario in which elective cardiac calcium scoring should be performed in a pregnant woman. If you think you may be pregnant, inform the imaging center before any CT scan.

Lactation. The scan uses no contrast agent (it is a non-contrast CT). Ionizing radiation does not persist in breast milk, so a CAC scan performed in a breastfeeding woman does not require pumping and discarding milk. Elective scans are generally deferred until after weaning simply to minimize cumulative lifetime radiation exposure, not because of a direct lactation risk.

Contraception relevance. CAC scoring itself has no contraception implications. The downstream medications that a high CAC score might prompt (statins, for example) do carry pregnancy safety concerns. Statins are FDA Pregnancy Category X: they are contraindicated in pregnancy and require reliable contraception in women of reproductive age who are prescribed them. The FDA prescribing information for atorvastatin states that the drug should be discontinued as soon as pregnancy is recognized.

Who This Test Is Right For, and Who It Is Not

Strong Candidates for CAC Scanning

• Women ages 45-75 with intermediate 10-year ASCVD risk (7.5%-20%) who are uncertain about starting a statin
• Women with premature menopause (before age 45) and any additional risk factor
• Women with a history of preeclampsia, hypertensive disorders of pregnancy, or gestational diabetes who are now in their forties
• Women with PCOS and at least one additional cardiovascular risk factor at age 40 or older
• Women whose 10-year risk score sits just below the threshold for statin treatment but who want an objective tie-breaker
• Women already on a statin wondering whether their therapy is adequate or whether it could be safely stopped

Women for Whom CAC Is Usually Not Indicated

• Women under 40 without familial hypercholesterolemia or another severe risk driver
• Women who are pregnant
• Women at high risk by Pooled Cohort Equations alone (above 20%), where the score will not change the clinical decision because statin therapy is already clearly indicated
• Women at very low risk (below 5%) where a high score would be a statistical outlier and management would not meaningfully change
• Women who have already had a coronary event (this test is for primary prevention)

Getting and Interpreting Your CAC Scan: Practical Steps

Most CAC scans take about ten minutes in the scanner and require no preparation other than removing metal from the chest area. No IV contrast is used. Results are typically reported within 24-48 hours.

When you receive your report, look for three things:

1. The Agatston score. The raw number.
2. The MESA percentile. If your radiology report does not include age, sex, and race-adjusted percentiles, use the online MESA calculator or ask your clinician to apply it.
3. The distribution of calcium. Which arteries are involved matters. Left anterior descending artery (LAD) calcium is associated with particularly high event rates. A score of 50 confined to a small segment of the right coronary artery carries a different implication than 50 distributed across the LAD.

Elena Vasquez, MD, WomanRx medical reviewer and board-certified cardiologist, puts it this way: "In my practice, the CAC scan has changed the most minds in perimenopausal women between 48 and 58 who look fine on paper but whose estrogen loss has quietly accelerated plaque accumulation for years. A score of 150 in a 52-year-old woman who thought she was low-risk is a very different conversation than the Pooled Cohort calculator alone would have generated."

Repeat CAC Scanning: Is One Scan Enough?

A single CAC scan is generally sufficient for primary prevention decision-making, and repeat scanning is not routinely recommended. The exception the guidelines acknowledge is the scenario in which the first scan returns a score of zero and five or more years have passed, during which time significant new risk factors have emerged (menopause, new diabetes diagnosis, marked LDL rise).

A 2019 analysis in JACC followed 3,267 initially zero-score adults over a median of nine years. About 15% of women who started with a zero score had detectable calcium by the follow-up scan, and those who converted to a positive score had substantially higher event rates than persistent zero-scorers. For women who enter menopause with a zero score, a repeat scan five to seven years later is a reasonable clinical discussion, even if not yet a firm guideline.